Paola Rogliani Selected Research

erdosteine

1/2021	Use of Thiols in the Treatment of COVID-19: Current Evidence.
11/2020	Multifaceted Beneficial Effects of Erdosteine: More than a Mucolytic Agent.
5/2019	Efficacy and safety profile of mucolytic/antioxidant agents in chronic obstructive pulmonary disease: a comparative analysis across erdosteine, carbocysteine, and N-acetylcysteine.
1/2018	Impact of erdosteine on chronic bronchitis and COPD: A meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paola Rogliani Research Topics

Disease

127	Chronic Obstructive Pulmonary Disease (COPD) 06/2022 - 10/2007
74	Asthma (Bronchial Asthma) 08/2022 - 04/2011
22	Inflammation (Inflammations) 07/2022 - 10/2007
14	COVID-19 04/2021 - 01/2020
12	Pneumonia (Pneumonitis) 02/2022 - 03/2004
9	Emphysema 11/2021 - 02/2002
8	Dyspnea (Shortness of Breath) 10/2021 - 12/2013
6	Cough 06/2022 - 05/2014
6	Airway Obstruction (Choking) 01/2022 - 10/2017
5	Chronic Bronchitis 06/2022 - 09/2015
5	Infections 01/2022 - 01/2019
5	Respiratory Hypersensitivity 11/2021 - 10/2020
5	Obstructive Lung Diseases (Obstructive Lung Disease) 03/2021 - 11/2009
5	Hypersensitivity (Allergy) 10/2017 - 03/2004
4	Chronic Cough 01/2022 - 07/2016
4	Wounds and Injuries (Trauma) 11/2021 - 05/2015
4	Lung Diseases (Lung Disease) 11/2020 - 04/2013
4	Respiratory Tract Infections (Respiratory Tract Infection) 12/2018 - 01/2016
3	Bronchiectasis 01/2022 - 01/2016
3	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2021 - 02/2013
3	Hypoxia (Hypoxemia) 10/2021 - 12/2013
3	Neoplasms (Cancer) 01/2021 - 01/2016
3	Cystic Fibrosis (Mucoviscidosis) 10/2019 - 01/2016
3	Chronic Disease (Chronic Diseases) 10/2019 - 01/2016
3	Idiopathic Pulmonary Fibrosis 03/2019 - 10/2016
3	Bronchial Spasm 01/2016 - 06/2013
2	Rhinosinusitis 01/2022 - 01/2016
2	Pain (Aches) 11/2021 - 11/2004
2	Cytokine Release Syndrome 01/2021 - 01/2021
2	Insulin Resistance 01/2021 - 01/2010

Drug/Important Bio-Agent (IBA)

47	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2022 - 12/2013
35	Bronchodilator Agents (Bronchodilators)IBA 06/2022 - 12/2009
28	Muscarinic AntagonistsIBA 07/2022 - 09/2011
15	Tiotropium Bromide (Spiriva)FDA Link 06/2022 - 12/2009
15	Pharmaceutical PreparationsIBA 01/2021 - 04/2011
11	Biological ProductsIBA 07/2022 - 07/2016
11	Cholinergic Agents (Cholinergics)IBA 06/2022 - 05/2014
11	Biomarkers (Surrogate Marker)IBA 06/2022 - 11/2009
11	Glycopyrrolate (Glycopyrronium Bromide)FDA LinkGeneric 01/2022 - 01/2015
10	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 06/2022 - 10/2012
10	indacaterolIBA 01/2022 - 01/2013
9	Acetylcysteine (Siran)FDA LinkGeneric 01/2021 - 09/2015
8	Monoclonal AntibodiesIBA 09/2021 - 04/2015
7	benralizumabIBA 02/2022 - 01/2019
7	Formoterol Fumarate (Oxis)FDA Link 04/2021 - 04/2013
6	Interleukin-5 (Interleukin 5)IBA 09/2021 - 01/2018
6	CytokinesIBA 01/2021 - 09/2016
6	AllergensIBA 01/2021 - 01/2016
6	Expectorants (Mucolytics)IBA 12/2020 - 01/2017
6	GoldIBA 07/2020 - 01/2018
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 01/2016
5	Oxygen (Dioxygen)IBA 10/2021 - 12/2013
5	Omalizumab (Xolair)FDA Link 09/2021 - 01/2019
5	reslizumabIBA 07/2021 - 02/2018
5	mepolizumabIBA 07/2021 - 01/2019
5	Albuterol (Salbutamol)FDA LinkGeneric 01/2021 - 04/2011
5	SteroidsIBA 12/2020 - 01/2018
4	GSK573719IBA 03/2022 - 12/2014
4	Beclomethasone (Beclometasone)FDA Link 04/2021 - 12/2018
4	erdosteineIBA 01/2021 - 01/2018
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 10/2012
3	vilanterolIBA 03/2022 - 01/2015
3	fluticasone furoate FDA Link 03/2022 - 01/2021
3	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2022 - 05/2017
3	LipopolysaccharidesIBA 01/2022 - 01/2017
3	Interleukin-13IBA 09/2021 - 04/2020
3	Immunoglobulin E (IgE)IBA 09/2021 - 10/2017
3	dupilumabIBA 09/2021 - 01/2019
3	ChemokinesIBA 01/2021 - 09/2016
3	AntioxidantsIBA 01/2021 - 01/2017
3	GlucocorticoidsIBA 12/2020 - 01/2014
3	doxofyllineIBA 01/2020 - 01/2018
3	pirfenidoneIBA 03/2019 - 10/2016
3	Theophylline (Theon)FDA LinkGeneric 01/2019 - 01/2018
3	RoflumilastIBA 01/2018 - 07/2016
3	Phosphodiesterase 4 InhibitorsIBA 08/2016 - 11/2014
2	Acetylcholine (Acetylcholine Chloride)FDA Link 06/2022 - 11/2021
2	AntigensIBA 01/2022 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2021
2	Mometasone Furoate (Nasonex)FDA LinkGeneric 01/2022 - 10/2021
2	3- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA 11/2021 - 07/2021
2	VaccinesIBA 10/2021 - 04/2021
2	tezepelumabIBA 09/2021 - 04/2020
2	Interleukin-4 (Interleukin 4)IBA 09/2021 - 01/2021
2	Humanized Monoclonal AntibodiesIBA 09/2021 - 04/2018
2	Budesonide (Pulmicort)FDA LinkGeneric 04/2021 - 01/2016
2	Messenger RNA (mRNA)IBA 03/2021 - 10/2020
2	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2010
2	Sulfhydryl Compounds (Thiols)IBA 01/2021 - 11/2020
2	Phosphodiesterase InhibitorsIBA 01/2021 - 11/2014
2	AerosolsIBA 01/2021 - 01/2018

Therapy/Procedure

85	Therapeutics 08/2022 - 10/2007
15	Nebulizers and Vaporizers (Inhaler) 08/2022 - 09/2011
6	Precision Medicine 09/2021 - 01/2017
5	Drug Therapy (Chemotherapy) 07/2022 - 01/2017
5	Pneumonectomy (Lung Volume Reduction) 11/2021 - 02/2002
3	Biological Therapy 07/2022 - 01/2018
3	Anesthesia 08/2018 - 11/2004
3	General Anesthesia 12/2016 - 02/2013
2	Length of Stay 11/2021 - 11/2004